Insights

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

This paper highlights macro and micro factors affecting oncology and proposes a partnership-driven framework to catalyze innovation for oncology-focused biopharma – as well as the role that select high-impact technologies will have on the on the entire value-chain of cancer research and care delivery. 

Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...

We are delighted to report a significant step forward as we grow our bioinnovation capability as we have received our licence from the UK Human Tissue Authority to store human tissue for research purposes. This opens the way to future development in cell therapies and regenerative medicine. 

Symon Cotton explores the use of pooled testing techniques for deploying mass Covid testing.  

James Hallinan's takeaway from SynBioBeta 2020: Synbio is growing up and getting ever more relevant to the everyday. 

With a constant stream of good news about potential COVID-19 vaccines, we reflect on traditional viral vaccine manufacturing processes and how we apply what we’re learning during this pandemic to legacy techniques.

The UK biotechnology scene is buzzing with debate right now, with critical themes like green growth and sustainability really coming to the fore. The pandemic has thrust science and scientists into the spotlight like never before – and each of us has a responsibility to contribute to the sort of response that will help create a more resilient world.  

Richard Hammond presents a seminar on Bioinnovation from Innovation Day UK 2019.

One of the advantages of my role here at Cambridge Consultants is getting to swap thoughts and opinions with some of the brightest minds in the bioeconomy. Collaborating with members of the SynBioBeta network...

Richard Hammond, Head of Synthetic Biology, discusses the advances being made in bioinnovation.

Our whitepaper looks at the potential of PHA bioplastics in the food service industry. We've designed a range of sustainable, biodegradable plastic products, all served up on a bioplastic tray...